Northern Trust’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Northern Trust's CODX Position: Q1 2026 in Review
Northern Trust sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,833 shares — an estimated $9.27K sold.
Northern Trust first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $5.95M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Northern Trust reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 1,833 Co-Diagnostics shares in Q1 2026, an estimated $9.27K.
- Northern Trust first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
- Northern Trust's Co-Diagnostics position peaked at $5.95M in Q2 2020.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.